The Latest Data on Combining Botox With Anti-CGRP Medications
Aug 07, 2020•16 min•Ep. 68
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
There has been much debate about combination therapy with Botox and anti-CGRP monoclonal antibodies including Aimovig, Ajovy, and Emgality. The two medications were not originally studied together leaving physicians uncertain about prescribing practices and many insurance companies unwilling to pay for both treatments. Dr. Lindsay Weitzel talks to Dr. Tim Smith about recent data on prescribing these two medications together. What does this mean for our community?
For the best experience, listen in Metacast app for iOS or Android